AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

MedX Health Corp

$0.03 +$0.01 (+127.27%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.03
Day Range
$0.03$0.04
Year Range
$0$0.05
Market Cap
8.2M
AVG Volume
16.07K
Trailing/Forward PE
-1.81/2.3
PEG ratio
0.01
Dividend Yield
-
Next Earnings Date
2026-12-02
Primary Exchange
Other OTCUS
Revenue (CAD) · TTM
0200K400K600K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDXHF Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
26 Q2570.19K
26 Q1540.27K
25 Q4473.15K
25 Q3522.9K
25 Q2478.25K
25 Q1494.04K
24 Q4489.7K
24 Q3367.99K
24 Q2388.64K
24 Q1514.09K
Net Income (CAD) · TTM
-8M-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDXHF Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
26 Q2-6.19M
26 Q1-5.9M
25 Q4-6.27M
25 Q3-5.3M
25 Q2-4.71M
25 Q1-4.32M
24 Q4-3.65M
24 Q3-3.15M
24 Q2-3.82M
24 Q1-4.28M
Operating Income (CAD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDXHF Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
26 Q2-4.28M
26 Q1-3.99M
25 Q4-4.28M
25 Q3-3.34M
25 Q2-2.95M
25 Q1-2.75M
24 Q4-2.3M
24 Q3-2.61M
24 Q2-2.95M
24 Q1-3M
EBITDA (CAD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDXHF EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
26 Q2-4.22M
26 Q1-3.94M
25 Q4-4.22M
25 Q3-3.29M
25 Q2-2.9M
25 Q1-2.71M
24 Q4-2.26M
24 Q3-2.56M
24 Q2-2.92M
24 Q1-2.97M
Cash Flows (CAD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDXHF Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
26 Q2-3.78M
26 Q1-4.04M
25 Q4-3.72M
25 Q3-3.16M
25 Q2-3.17M
25 Q1-2.54M
24 Q4-2.51M
24 Q3-2.53M
24 Q2-2.46M
24 Q1-2.52M
EPS (CAD) · TTM
-0.03-0.02-0.01024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDXHF EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
26 Q2-0.02
26 Q1-0.02
25 Q4-0.02
25 Q3-0.02
25 Q2-0.02
25 Q1-0.02
24 Q4-0.01
24 Q3-0.01
24 Q2-0.02
24 Q1-0.02
Expenses (CAD) · TTM
02M4M6MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDXHF Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
26 Q24.07M
26 Q13.77M
25 Q44.02M
25 Q33.27M
25 Q22.9M
25 Q12.65M
24 Q42.2M
24 Q32.42M
24 Q22.68M
24 Q12.78M
Shares Outstanding (CAD) · TTM
-1M-500K0500K1MBuybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
MDXHF Shares Outstanding (CAD) · TTM by quarter
PeriodShares Outstanding (CAD) · TTM
26 Q2-249.77K
26 Q1-269.07K
25 Q4-866.98K
25 Q3-702.27K
25 Q2-686.08K
25 Q1-687.71K
24 Q4-138.4K
24 Q3414.48K
24 Q2415.33K
24 Q1221.85K
Free Cash Flow Yield
-1000%-750%-500%-250%0%med -77.86%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDXHF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-35.53%
Sep 26-35.63%
Aug 26-35.45%
Aug 26-35.81%
Aug 26-35.52%
Aug 26-35.36%
Jul 26-19.85%
Jul 26-20.33%
Jul 26-20.44%
Jul 26-20.25%
Jul 26-72.4%
Jun 26-19.04%
Jun 26-72.97%
Jun 26-18.44%
Jun 26-18.5%
May 26-18.71%
May 26-18.67%
May 26-18.76%
May 26-18.86%
May 26-18.98%
Apr 26-19%
Apr 26-18.97%
Apr 26-18.64%
Apr 26-18.53%
Mar 26-17.14%
Mar 26-17.36%
Mar 26-17.36%
Mar 26-17.56%
Feb 26-17.46%
Feb 26-36.49%
Feb 26-36.65%
Feb 26-36.5%
Jan 26-36.64%
Jan 26-36.43%
Jan 26-25.1%
Jan 26-25.11%
Jan 26-69.39%
Dec 25-72.57%
Dec 25-71.91%
Dec 25-79.26%
Dec 25-79%
Nov 25-78.12%
Nov 25-77.42%
Nov 25-77.85%
Nov 25-77.71%
Oct 25-77.95%
Oct 25-77.99%
Oct 25-77.86%
Oct 25-15.6%
Oct 25-15.97%
Sep 25-13.67%
Sep 25-16.95%
Sep 25-843.14%
Sep 25-844.36%
Aug 25-849.63%
Aug 25-844.56%
Aug 25-844.94%
Aug 25-848.62%
Aug 25-846.6%
Jul 25-852.14%
Jul 25-850.84%
Jul 25-852.93%
Jul 25-859.38%
Jun 25-860.3%
Jun 25-856.88%
Jun 25-866.6%
Jun 25-859.63%
May 25-856.7%
May 25-857.18%
May 25-842.57%
May 25-844.7%
May 25-851.93%
Apr 25-849.72%
Apr 25-850.66%
Apr 25-848.8%
Apr 25-827.16%
Mar 25-834.4%
Mar 25-832.21%
Mar 25-831.06%
Mar 25-831.5%
Feb 25-825.93%
Feb 25-840.08%
Feb 25-842.19%
Feb 25-835.93%
Jan 25-822.3%
Jan 25-832.79%
Jan 25-824.8%
Jan 25-828.37%
Jan 25-826.85%
Dec 24-805%
Dec 24-807.24%
Dec 24-815.28%
Dec 24-819.73%
Nov 24-828.57%
Nov 24-830.23%
Nov 24-823.63%
Nov 24-16.69%
Nov 24-16.64%
Oct 24-16.7%
Oct 24-13.45%
Price to Sales
0204060med 8.52Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MDXHF Price to Sales by quarter
PeriodPrice to Sales
Sep 2621.05
Sep 2620.99
Aug 2621.09
Aug 2620.88
Aug 2621.05
Aug 2621.15
Jul 2637.68
Jul 2636.78
Jul 2636.59
Jul 2636.93
Jul 2610.33
Jun 2641.3
Jun 2610.78
Jun 2642.65
Jun 2642.5
May 2642.04
May 2642.13
May 2641.91
May 2641.7
May 2641.43
Apr 2641.39
Apr 2641.46
Apr 2642.2
Apr 2642.44
Mar 2635.27
Mar 2634.84
Mar 2634.84
Mar 2634.43
Feb 2634.63
Feb 2616.57
Feb 2616.5
Feb 2616.57
Jan 2616.5
Jan 2616.6
Jan 2624.09
Jan 2624.08
Jan 268.71
Dec 259.14
Dec 259.23
Dec 258.37
Dec 258.4
Nov 258.49
Nov 258.57
Nov 258.52
Nov 258.54
Oct 258.51
Oct 258.51
Oct 258.52
Oct 2542.55
Oct 2541.54
Sep 2537.64
Sep 2530.36
Sep 250.61
Sep 250.61
Aug 250.61
Aug 250.61
Aug 250.61
Aug 250.61
Aug 250.61
Jul 250.6
Jul 250.6
Jul 250.6
Jul 250.6
Jun 250.6
Jun 250.6
Jun 250.59
Jun 250.6
May 250.6
May 250.6
May 250.61
May 250.61
May 250.6
Apr 250.6
Apr 250.6
Apr 250.6
Apr 250.62
Mar 250.82
Mar 250.83
Mar 250.83
Mar 250.83
Feb 250.83
Feb 250.82
Feb 250.82
Feb 250.82
Jan 250.84
Jan 250.82
Jan 250.83
Jan 250.83
Jan 250.83
Dec 240.78
Dec 240.78
Dec 240.78
Dec 240.77
Nov 240.76
Nov 240.76
Nov 240.77
Nov 2437.87
Nov 2437.98
Oct 2437.83
Oct 2446.98
MedX Health Corp
MDXHF
Stockpicker

Video analysis: MDXHF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.